PURPOSE: Results are reported from an aggressive chemoradiotherapy protocol for
advanced squamous cell head and neck cancer. PATIENTS AND METHODS: Patients with …

Purpose: To determine the toxicity and efficacy of concurrent 5-fluorouracil (5-FU), cisplatin,
and paclitaxel (Taxol) and hyperfractionated radiotherapy in locally advanced squamous …

PURPOSE: To evaluate efficacy and toxicity of the Duke University chemoirradiation
regimen for locally advanced head-and-neck cancer in a regional community cancer center …

PURPOSE To determine tumor response rate, patterns of failure, toxicity, and survival in
advanced squamous head and neck cancer after a combined treatment program that …

Purpose A retrospective review with long-term follow-up is reported from the Cleveland
Clinic Foundation studying radiation and concurrent multiagent chemotherapy in patients …

PURPOSE To evaluate an intensive concomitant chemoradiotherapy protocol of
conventional radiotherapy with intermittent cisplatin (CDDP) and continuous-infusion …

In January 1988, we initiated a prospective study evaluating a new treatment approach with
chemotherapy and radiotherapy for unresectable head and neck cancer. Weeks 1–4 were …

AIMS: Hypofractionated accelerated radiotherapy with concurrent carboplatin utilises both
advantages of altered fractionation and synchronous chemotherapy to maximise local …

Background Since 1989, 105 patients with squamous head and neck cancer have been
treated with combined chemoradiotherapy. Objective To examine the effectiveness of using …

Improving the outcome for patients with locally advanced head and neck carcinomas (HNC)
by rational modification of radiation fractionation regimens or combinations of radiation with …